Incyte Corporation vs PPG Industries, Inc. — how do they compare? Incyte Corporation trades at $120.45 (market cap $24.54B), while PPG Industries, Inc. trades at $116.16 (market cap $25.82B). The key difference: Incyte Corporation and PPG Industries, Inc. are close in size by market cap, and PPG Industries, Inc. pays a 2.55% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.
| INCY | PPG | |
|---|---|---|
Market Cap | $24.54B | $25.82B |
Sector | Health | Basic Materials |
52-Week High | $129.93 | $131.56 |
52-Week Low | $81.61 | $94.34 |
Enterprise Value | $20.04B | $31.69B |
Dividend Yield | — | 2.55% |
Trailing returns across standard periods
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →